주식회사 건강약품 / HEALTH PARM
HEALTH PARM's KOBDi Score is 116.93 as of Sep 2026, up 1.79 points since Apr 2025; it rose in 4 and fell in 1 of the 12 monthly updates. As of Sep 2026 it is ahead of about 68% of companies in its industry, against 68% in Aug 2026 and 59% in Apr 2025. Its strongest position was 69% (Apr 2026) and its weakest 59% (Apr 2025).
A year earlier, in Aug 2025, its score was 117.60 and it was ahead of about 61% of companies in its industry.
| Sep 2026 | 116.93 | ahead of 68% |
| Aug 2026 | 116.85 | ahead of 68% |
| Jul 2026 | 116.85 | ahead of 67% |
| Jun 2026 | 116.85 | ahead of 67% |
| May 2026 | 117.86 | ahead of 68% |
| Apr 2026 | 117.86 | ahead of 69% |
| Mar 2026 | 117.86 | ahead of 68% |
| Feb 2026 | 117.76 | ahead of 68% |
| Dec 2025 | 117.76 | ahead of 66% |
| Aug 2025 | 117.60 | ahead of 61% |
| Jul 2025 | 115.14 | ahead of 60% |
| May 2025 | 115.14 | ahead of 60% |
| Apr 2025 | 115.14 | ahead of 59% |
Where is HEALTH PARM located?
HEALTH PARM is registered at 서울특별시 서초구 남부순환로, South Korea (postal code 06725).
What industry is HEALTH PARM in?
HEALTH PARM belongs to Manufacturing › Pharmaceuticals & Biologics › Finished pharmaceutical manufacturing.
How many employees does HEALTH PARM have?
HEALTH PARM has 5–9 employees.
What is HEALTH PARM's KOBDi Score?
116.93 as of September 2026, ahead of about 68% of companies in its industry.
Who are HEALTH PARM's competitors?
Similar companies include JoongHun Pharm, DANIL GASCHEM and qnq parm.


